Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval
Québec, Quebec, G1V4G5, Canada
NCT Number: NCT07175740
The goal of this randomized crossover trial is to evaluate the impact of meal macronutrient composition on the glycemic response following exercise in males with type 2 diabetes. The main question it aims to answer is:
• Is the consumption of a glucose enriched meal associated with a bigger reduction in plasma glucose following a 1-hour exercise session than other meals Researchers will compare different meal macronutrient composition to see how it affects the glycemic response after exercise.
Participants will
* Fast, then do a 1-hour exercise session * Eat a glucose enriched meal, then do a 1-hour exercise session * Eat a fructose enriched meal, then do a 1-hour exercise session * Eat a fat enriched meal, then do a 1-hour exercise session * Eat an aspartame enriched meal, then do a 1-hour exercise session
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
Québec, Quebec, G1V4G5, Canada
Meals The meals will be equivalent in terms of total calories (with the exception of the aspartame meal) and the percentage of protein will be the same in all four conditions. Only the fat and carbohydrates percentages will vary in the four meal conditions.
Exercise protocol Each subject will perform a maximal aerobic capacity (VO2peak) test on an ergocycle at the start of the protocol. Subsequently, at one-week intervals, each patient will perform an exercise session consisting of one hour of ergocycle at a capacity corresponding to 60% of each individual's VO2peak. The prescribed workload will be established based on the VO2peak test. Exercise will be monitored using heart rate, work, and oxygen consumption measured using an indirect calorimetry system. The five conditions will be randomized and performed at one-week intervals. Each exercise session will be supervised by a physician. Patients taking oral hypoglycemic agents will not take their medication on the morning of the exercise.
Blood samples Samples will be taken to measure glucose, free fatty acids, insulin, glucagon, and plasma catecholamines. In addition, an indirect calorimetry system will allow us to measure total substrate oxidation. For each blood sample period, there will be a 5-minute assessment as described above.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No meal
175 ml of oatmeal cereal, one slice of bread, 30g of cheese, 22g sucrose
175 ml of oatmeal cereal, one slice of bread, 30g of cheese, 22g fructose
175 ml of oatmeal cereal, one slice of bread, 30g of cheese, 15g fat
175 ml of oatmeal cereal, one slice of bread, 30g of cheese, aspartame (matched for taste)
A 60-minutes exercise session on a cycle ergometer (Corival 400, Quinton Instruments, Seattle, WA, USA) at 60% of the VO2peak (determined at a baseline visit)
Time frame: Plasma glucose and insulin levels from blood samples taken at -15, 0, 15, 30, 45, 60, 75 and 90 minutes from the beginning of the exercise.
Plasma glucose and insulin levels following consumption of different meal compositions and following a 1-hour exercise session.
Paul Poirier
Other
Influence of the Macronutrient Content of a Standardized Pre-Exercise Meal on the Glycemic Response Following Exercise in Type 2 Diabetics
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06268743
Behavior, Diabetes Mellitus
Fredericton, New Brunswick, Canada
View Trial DetailsNCT05524909
Behavior, Diabetes Mellitus
Hong Kong
View Trial DetailsNCT05830318
Asthma, Behavior
Leicester, United Kingdom
View Trial DetailsNCT01207349
Behavior, Diabetes Mellitus
Saint-Pierre, La Réunion, France
View Trial Details